Electronic Trial Master File (eTMF) Systems Market | Ongoing Trends and Recent Developments | Major Key Players like Veeva Systems (US), Oracle Corporation (US), Phlexglobal Limited (UK)

Factors such as rising adoption of Electronic Trial Master File (eTMF) Systems, rising number of clinical trials, partnerships between biopharma companies and CROs, rising funding to support clinical trials, and the growth in the R&D spending by pharma & biotech companies are driving the growth of the eTMF systems market.

What the Electronic Trial Master File (eTMF) Systems Market Looks Like?

Predicted to grow at a CAGR of 12.7% during the forecast period, the global Electronic Trial Master File (eTMF) Systems market is estimated to reach USD 1.8 billion by the end of 2024. In 2018, North America dominated the eTMF systems market; this trend to continue during the forecast period

Based on end-user, the eTMF systems market is segmented into pharmaceutical & biotechnology companies, contract research organizations (CROs), and other end-users (medical device companies, academic research institutes, and consulting service companies). The pharmaceutical & biotechnology companies segment accounted for the largest market share in 2018. The increasing applications of eTMF software in clinical project management and the availability of substantial R&D budgets with large pharmaceutical & biotechnology companies will drive the adoption of eTMF systems in this end-user segment.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94357456

Based on the component, the Electronic Trial Master File (eTMF) Systems Market is segmented into services and software. The services segment accounted for the largest market share in 2018. The large share of this segment can be attributed to their indispensable nature and repetitive requirement. End-users of eTMF systems rely heavily on service providers for consulting, data storage, implementing services, training, maintenance, and regular upgrades of solutions.

Based on delivery mode, the market is segmented into on-premise and cloud-based eTMF. In 2018, the cloud-based eTMF segment accounted for the largest share of the market. The large share of this segment is primarily due to the flexible, scalable, and affordable nature of this delivery mode.

What Drives the Market?

The growth of the global market for Electronic Trial Master File (eTMF) Systems is primarily influenced by the following factors:

• Rising Adoption of eTMF Systems
• Rising Number of Clinical Trials
• Rising Government Funding and Grants to Support Clinical Trials
• Increasing R&D Expenditure by Pharma-Biotech Companies and It Expenditure Allocations

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=94357456

Geographical growth scenario of Electronic Trial Master File (eTMF) Systems Market:

Geographically, the eTMF systems market is divided into North America, Europe, Asia Pacific, and the Rest of the World (RoW). The North American market accounted for the largest share of the eTMF systems market in 2018, primarily due to the increasing government funding for clinical research and a large number of clinical trials. Several major global players are also based in the US, owing to which the country has become a center of innovation in the eTMF systems.

Leading market players and strategies adopted:

The prominent players in the Electronic Trial Master File (eTMF) Systems market include Veeva Systems (US), Oracle Corporation (US), Phlexglobal Limited (UK), TransPerfect Global Inc. (US), Aurea Software (US), LabCorp (US), ePharmaSolutions (US), Wingspan Technology, Inc. (US), MasterControl (US), SureClinical, Inc. (US), Dell EMC (US), Paragon Solutions (US), PharmaVigilant (US), Mayo Clinic (US), Database Integrations, Inc. (US), CareLex (US), Ennov (France), Forte Research (US), Freyr (US), Montrium (US), NCGS Inc. (US), SAFE-BioPharma (US), SterlingBio Inc. (US), BIOVIA Corp. (US), and arivis AG (Germany)

Read More in Detailed: https://www.marketsandmarkets.com/PressReleases/electronic-trial-master-file-system.asp

Contact Us:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.